Cargando…

The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count

Programmed cell death ligand‐1 (PD‐L1) is a ligand for programmed cell death‐1 (PD‐1) that negatively regulates T‐cell activation and plays a crucial role in suppressing anti‐tumor host immunity. Although PD‐L1 is a promising immunotherapy target in various cancers, including urothelial carcinoma (U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyama, Yu, Morikawa, Teppei, Miyakawa, Jimpei, Koyama, Yuichi, Kawai, Taketo, Kume, Haruki, Fukayama, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143937/ https://www.ncbi.nlm.nih.gov/pubmed/30062756 http://dx.doi.org/10.1002/cam4.1686

Ejemplares similares

Lipid Cell and Micropapillary Variants of Urothelial Carcinoma of the Ureter
por: Miyama, Yu, et al.
Publicado: (2015)

Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma
por: Teshima, Taro, et al.
Publicado: (2022)

Adenoma-carcinoma Sequence in the Bladder After Augmentation Cystoplasty
por: Naito, Akihiro, et al.
Publicado: (2014)

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma
por: Sugimoto, Kazuma, et al.
Publicado: (2022)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette–Guerin immunotherapy
por: Kurokawa, Yoshiaki, et al.
Publicado: (2021)

Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT
por: Takahashi, Miwako, et al.
Publicado: (2015)

Adenocarcinoma at Anastomotic Site of Ureterosigmoidostomy Potentially of Urothelial Origin Spreading to the Upper Urinary Tract
por: Makino, Katsuhiro, et al.
Publicado: (2015)

The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy
por: Takeshima, Yuta, et al.
Publicado: (2022)

Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model
por: Taguchi, Satoru, et al.
Publicado: (2020)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort
por: Urabe, Masayuki, et al.
Publicado: (2018)

Metastatic Small Intestinal Cancer of the Urinary Bladder
por: Morikawa, Teppei, et al.
Publicado: (2010)

A rare case of de novo large cell neuroendocrine carcinoma of the prostate with long-term survival after cystoprostatectomy and androgen deprivation
por: Miyakawa, Jimpei, et al.
Publicado: (2018)

Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization
por: Musangile, Fidele Y., et al.
Publicado: (2021)

Repeatability of antral follicle count according parity in dairy cows
por: KOYAMA, Keisuke, et al.
Publicado: (2018)

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer
por: Joshi, Monika, et al.
Publicado: (2020)

Asymptomatic renal granuloma diagnosed 3 years after Bacillus Calmette–Guérin intravesical injection: A case report and a literature review
por: Tsuru, Ibuki, et al.
Publicado: (2023)

Improved survival in real‐world patients with advanced urothelial carcinoma: A multicenter propensity score‐matched cohort study comparing a period before the introduction of pembrolizumab (2003–2011) and a more recent period (2016–2020)
por: Taguchi, Satoru, et al.
Publicado: (2022)

Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade
por: Asai, Akihiro, et al.
Publicado: (2017)

The ‘prostate-muscle index’: a simple pelvic cavity measurement predicting estimated blood loss and console time in robot-assisted radical prostatectomy
por: Kimura, Naoki, et al.
Publicado: (2022)

Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
por: Taguchi, Satoru, et al.
Publicado: (2021)

Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
por: Shao, Yilin, et al.
Publicado: (2021)

c‐Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling
por: Taguchi, Luna, et al.
Publicado: (2019)

Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

Nose size indicates maximum penile length
por: Ikegaya, Hiroshi, et al.
Publicado: (2021)

A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy
por: Taguchi, Satoru, et al.
Publicado: (2023)

HER2 as a target in invasive urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
por: Kawai, Taketo, et al.
Publicado: (2022)

Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy
por: Kobayashi, Reiko, et al.
Publicado: (2016)

Prostasin regulates PD-L1 expression in human lung cancer cells
por: Chen, Li-Mei, et al.
Publicado: (2021)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
por: Springer, Simeon U, et al.
Publicado: (2018)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

PD-L1 regulates tumorigenesis and autophagy of ovarian cancer by activating mTORC signaling
por: Gao, Hongmin, et al.
Publicado: (2019)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Interpretation According to Clone-Specific PD-L1 Cutoffs Reveals Better Concordance in Muscle-Invasive Urothelial Carcinoma
por: Huang, Tzu-Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qs67knavbrvaf6vsua0rel0al1